This is a preview of subscription content, log in via an institution to check access.
References
Nielsen-Kudsk JE, Buhl JS, Johannessen AC (1990) Verapamil-induced inhibition of theophylline in healthy humans. Pharmacol Toxicol 66: 101–103
Robson RA, Miners JO, Matthews AP, Stupans I, Meller D, McManus M, Birkett DJ (1988) Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies. Biochem Pharmacol 37: 1651–1659
Butler MA, Iwasaki M, Guengerich FP, Kadlubar FK (1989) Human cytochrome P450PA (P-450IA2), the phenacetin O-deethylase, is primary responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 86: 7696–7700
Fuhr U, Wolff T, Harder S, Schymanski P, Staib AH (1990) Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes. Drug Metabol Dispos 18: 1005–1010
Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, de la Torre R, Davies DS (1990) Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. Br J Clin Pharmacol 29: 651–663
Kroemer HK, Beaune P, Henderson CJ, Wolf CR, Heidemann H (1991) Identification of cytochrome P-450 isozymes involved in the metabolism of verapamil. Arch Pharmacol 343 [Suppl]: R124
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fuhr, U., Woodcock, B.G. & Siewert, M. Verapamil and drug metabolism by the cytochrome P450 isoform CYP1A2. Eur J Clin Pharmacol 42, 463–464 (1992). https://doi.org/10.1007/BF00280138
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00280138